FDA to discuss Pfizer COVID-19 vaccine approval for kids ages 5-11

Within a week, the U.S. Food and Drug Administration Advisory Committee is scheduled to discuss the emergency use authorization for Pfizer’s COVID-19 vaccine for kids ages five to 11.